280,88 €
312,09 €
-10% with code: EXTRA
Mesothelioma
Mesothelioma
280,88
312,09 €
  • We will send in 10–14 business days.
Mesothelioma is an aggressive cancer with very poor survival and lack of treatment options. This book, written by a diverse panel of experts, presents a description of the most relevant topics on epidemiology, diagnosis, biomarkers, and treatment updates, including interesting discussion on molecular mechanisms, prognostic features, and novel therapies that are either approved or under clinical development for this challenging disease. It also discusses and explains genetic biomarkers, as there…
  • Publisher:
  • Year: 2020
  • Pages: 120
  • ISBN-10: 1839681543
  • ISBN-13: 9781839681547
  • Format: 17 x 24.4 x 0.8 cm, hardcover
  • Language: English
  • SAVE -10% with code: EXTRA

Mesothelioma (e-book) (used book) | bookbook.eu

Reviews

Description

Mesothelioma is an aggressive cancer with very poor survival and lack of treatment options. This book, written by a diverse panel of experts, presents a description of the most relevant topics on epidemiology, diagnosis, biomarkers, and treatment updates, including interesting discussion on molecular mechanisms, prognostic features, and novel therapies that are either approved or under clinical development for this challenging disease. It also discusses and explains genetic biomarkers, as there may be a role for some nuclear regulatory genes and proteins in development of mesothelioma, although targeted therapies so far have had limited impact.

EXTRA 10 % discount with code: EXTRA

280,88
312,09 €
We will send in 10–14 business days.

The promotion ends in 13d.13:19:23

The discount code is valid when purchasing from 10 €. Discounts do not stack.

Log in and for this item
you will receive 3,12 Book Euros!?
  • Publisher:
  • Year: 2020
  • Pages: 120
  • ISBN-10: 1839681543
  • ISBN-13: 9781839681547
  • Format: 17 x 24.4 x 0.8 cm, hardcover
  • Language: English English

Mesothelioma is an aggressive cancer with very poor survival and lack of treatment options. This book, written by a diverse panel of experts, presents a description of the most relevant topics on epidemiology, diagnosis, biomarkers, and treatment updates, including interesting discussion on molecular mechanisms, prognostic features, and novel therapies that are either approved or under clinical development for this challenging disease. It also discusses and explains genetic biomarkers, as there may be a role for some nuclear regulatory genes and proteins in development of mesothelioma, although targeted therapies so far have had limited impact.

Reviews

  • No reviews
0 customers have rated this item.
5
0%
4
0%
3
0%
2
0%
1
0%
(will not be displayed)